Cargando…

Polyvalent Human Immune Globulin: A Prospective, Open-Label Study Assessing Anti-Hepatitis A Virus (HAV) Antibody Levels, Pharmacokinetics, and Safety in HAV-Seronegative Healthy Subjects

BACKGROUND: Analytical data suggesting that immunoglobulin given intramuscularly (IGIM) may have reduced protection against hepatitis A virus (HAV) infection led to an update in the recommended IGIM dose (0.2 ml/kg). METHODS: This prospective, open-label, single-arm clinical study evaluated whether...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kankam, Martin, Griffin, Rhonda, Price, Jeffrey, Michaud, Josée, Liang, Wei, Llorens, Mariona Bassas, Sanz, Ana, Vince, Bradley, Vilardell, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467477/ https://www.ncbi.nlm.nih.gov/pubmed/32301062 http://dx.doi.org/10.1007/s12325-020-01327-9

Ejemplares similares

A simple and rapid Hepatitis A Virus (HAV) titration assay based on antibiotic resistance of infected cells: evaluation of the HAV neutralization potency of human immune globulin preparations
por: Konduru, Krishnamurthy, et al.
Publicado: (2008)

HAV Immunity in Iranian Medical Students
por: Hosseini Shokouh, Seyyed Javad, et al.
Publicado: (2015)

No IL-18BP? Avoid HAV
por: Diamond, Michael S.
Publicado: (2019)

HAV Infection Associated with Hemophagocytic Syndrome
por: Aamri, H., et al.
Publicado: (2023)

Nachrichten des Deutschen Hausärzteverbands (HÄV)
Publicado: (2023)

A Recombinant HAV Expressing a Neutralization Epitope of HEV Induces Immune Response against HAV and HEV in Mice
por: Kui, Xiang, et al.
Publicado: (2017)

Natural Products and Their Potential Anti-HAV Activity
por: Jama-Kmiecik, Agnieszka, et al.
Publicado: (2021)

Hepatitis A virus (HAV) packaging size limit
por: Konduru, Krishnamurthy, et al.
Publicado: (2009)

921. Acute HAV Infection in an Inpatient Psychiatry Unit
por: Weston, Gregory, et al.
Publicado: (2021)

In-hospital post-transplant acute hepatitis A viral (HAV) infection in a liver transplant recipient who was HAV seropositive pre-transplant
por: Zhu, Julie, et al.
Publicado: (2019)

Sporadic Hepatitis A Virus PCR False-Positive Results Observed during Reflex Testing of Serum Samples Previously Tested for Anti-HAV Antibodies and Caused by Contamination with HAV RNA Present in the Reagents of the Commercial Anti-HAV Immunoassay
por: Lunar, Maja M., et al.
Publicado: (2023)

Prevalence of HAV and HEV in the patients presenting with acute viral hepatitis
por: Rao, Pooja, et al.
Publicado: (2012)

Synthesis of Some New Pyridazine Derivatives for Anti-HAV Evaluation
por: Flefel, Eman M., et al.
Publicado: (2017)

Sensory perception testing by monofilaments in the digits of controls and workers with HAVS
por: Poole, C. J. M., et al.
Publicado: (2020)

The HAV pattern in pediatric patients with atrioventricular node reentrant tachycardia
por: Moltedo, Jose M., et al.
Publicado: (2020)

Assessment of two alternative standardised tests for the vascular component of the hand–arm vibration syndrome (HAVS)
por: Ye, Ying, et al.
Publicado: (2016)

Assessment of thermotactile and vibrotactile thresholds for detecting sensorineural components of the hand–arm vibration syndrome (HAVS)
por: Ye, Ying, et al.
Publicado: (2017)

Tremor and hand-arm vibration syndrome (HAVS) in road maintenance workers
por: Bast-Pettersen, Rita, et al.
Publicado: (2016)

HAV‐induced acalculous cholecystitis: A case report and literature review
por: Salajegheh, Faranak, et al.
Publicado: (2023)

HAV in fresh vegetables: a hidden health risk in district Mardan, Pakistan
por: Khan, Waleed, et al.
Publicado: (2014)

Very low prevalence of anti-HAV in Japan: high potential for future outbreak
por: Yamamoto, Chikako, et al.
Publicado: (2019)

Functional recombinant human anti-HAV antibody expressed in milk of transgenic mice
por: Zhang, Ran, et al.
Publicado: (2009)

The Human Acellular Vessel (HAV) as a vascular conduit for infrainguinal arterial bypass
por: Farazdaghi, Armin, et al.
Publicado: (2023)

Viability RT-qPCR to Distinguish Between HEV and HAV With Intact and Altered Capsids
por: Randazzo, Walter, et al.
Publicado: (2018)

Food-Borne Viruses in Shellfish: Investigation on Norovirus and HAV Presence in Apulia (SE Italy)
por: La Bella, G., et al.
Publicado: (2016)

OL-044 HAV seroprevalence among children with 10 24 month ages in Ulaanbaatar
por: Sarangua, G., et al.
Publicado: (2008)

2509. Association of Non-Alcoholic Fatty Liver Disease with HBV, HAV, and HEV Exposure
por: Vassilopoulos, Stephanos, et al.
Publicado: (2023)

Detection of Antibodies against Hepatitis A Virus (HAV) by a Surface Plasmon Resonance (SPR) Biosensor: A New Diagnosis Tool Based on the Major HAV Capsid Protein VP1 (SPR-HAVP1)
por: dos Santos, Gabriel Menezes Costa, et al.
Publicado: (2021)

Inhibitory effects on HAV IRES-mediated translation and replication by a combination of amantadine and interferon-alpha
por: Yang, Lingli, et al.
Publicado: (2010)

Hepatitis A virus infection: Is it an important hazard to public health?: hazards of HAV for public health
por: Saberifiroozi, Mehdi
Publicado: (2011)

Increased seroprevalence of HAV and parvovirus B19 in children and of HEV in adults at diagnosis of autoimmune hepatitis
por: Taubert, Richard, et al.
Publicado: (2018)

Health economic assessment of universal immunization of toddlers against Hepatitis A Virus (HAV) in Mexico
por: Carlos, Fernando, et al.
Publicado: (2015)

The Medicinal Chemistry of Antihepatitis Agents I: Anti-HAV, Anti-HDV, and Anti-HEV Agents
por: Gupta, Satya P.
Publicado: (2018)

Synthesis and testing of azaglutamine derivatives as inhibitors of Hepatitis A Virus (HAV) 3C proteinase
por: Huang, Yanting, et al.
Publicado: (1999)

HAV infection in Brazilian men who have sex with men: The importance of surveillance to avoid outbreaks
por: Castro, Lisie Souza, et al.
Publicado: (2021)

ZC3HAV1 promotes the proliferation and metastasis via regulating KRAS in pancreatic cancer
por: Huang, Wei, et al.
Publicado: (2021)

P564: HOMOHARRINGTONINE AND CYTARABINE COMBINED WITH VENETOCLAX (HAV) FOR ADULT PATIENTS WITH DE NOVO AML
por: Luo, Xiao-Hua, et al.
Publicado: (2023)

Prevalence of IgG anti-HAV in patients with chronic hepatitis B and in the general healthy population in Korea
por: Lee, Sang Ho, et al.
Publicado: (2010)

Biotransformation of Indigo Pigment by Indigenously Isolated Pseudomonas sp. HAV-1 and Assessment of Its Antioxidant Property
por: Dua, Aditi, et al.
Publicado: (2014)

Changes in hepatitis A virus (HAV) seroprevalence in medical students in Bangkok, Thailand, from 1981 to 2016
por: Sintusek, Palittiya, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_f7v7u4dpa2nclisv7j88tjhuo4